- Home
- VSTE vs DRRX Comparison
VSTE vs DRRX Comparison
Compare VSTE & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- DRRX
- Stock Information
- Founded
- VSTE 2009
- DRRX 1998
- Country
- VSTE Australia
- DRRX United States
- Employees
- VSTE N/A
- DRRX N/A
- Industry
- VSTE
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- DRRX Health Care
- Exchange
- VSTE Nasdaq
- DRRX Nasdaq
- Market Cap
- VSTE 51.9M
- DRRX 44.4M
- IPO Year
- VSTE N/A
- DRRX 2000
- Fundamental
- Price
- VSTE $1.71
- DRRX $0.95
- Analyst Decision
- VSTE
- DRRX Buy
- Analyst Count
- VSTE 0
- DRRX 2
- Target Price
- VSTE N/A
- DRRX $5.00
- AVG Volume (30 Days)
- VSTE 8.3M
- DRRX 83.1K
- Earning Date
- VSTE 01-01-0001
- DRRX 11-13-2024
- Dividend Yield
- VSTE N/A
- DRRX N/A
- EPS Growth
- VSTE N/A
- DRRX N/A
- EPS
- VSTE N/A
- DRRX N/A
- Revenue
- VSTE $342,000.00
- DRRX $8,594,000.00
- Revenue This Year
- VSTE N/A
- DRRX N/A
- Revenue Next Year
- VSTE N/A
- DRRX $3.07
- P/E Ratio
- VSTE N/A
- DRRX N/A
- Revenue Growth
- VSTE N/A
- DRRX N/A
- 52 Week Low
- VSTE $0.83
- DRRX $0.48
- 52 Week High
- VSTE $12.00
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- VSTE 46.19
- DRRX 28.14
- Support Level
- VSTE $1.51
- DRRX $0.84
- Resistance Level
- VSTE $2.45
- DRRX $1.36
- Average True Range (ATR)
- VSTE 0.80
- DRRX 0.12
- MACD
- VSTE -0.18
- DRRX -0.05
- Stochastic Oscillator
- VSTE 1.60
- DRRX 10.30
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .